mpl logo dark

In the media

Metabolic Psychiatry Labs and our founding team are defining how mental health is understood and treated through a metabolic lens. Led by Stanford physician-scientist Dr. Shebani Sethi, MPL’s clinical research and care model have shaped national conversations on serious mental illness, nutrition, and brain health.

Recent Coverage

Dec. 13, 2024
Stanford Medicine News Center

Stanford Medicine's top scientific advancements of 2024

Dr. Sethi's research on dietary interventions (ketogenic diet) treating severe mental illnesses.

Media Mention
Media Mention
June 2024
The Federalist

Is America’s Trillion-Dollar Obesity Problem Here To Stay?

Holistic, lifestyle-based solutions like metabolic treatments (ketogenic therapy) for obesity and mental health.

Expert Commentary
Expert Commentary
April 23, 2025
Stanford Report

Stanford Medicine expert shares five key insights on keto therapy and mental illness

Ketogenic therapy for psychiatric symptoms, weight, and metabolic disorders in serious mental illness.

Media Mention
Media Mention
July 2024
bpHope

Metabolic Psychiatry: A New Era in Bipolar Disorder Treatment

Ketogenic therapy for bipolar disorder; Dr. Sethi's pioneering clinical studies.

Expert Commentary
Expert Commentary
Dec. 17, 2024
Bloomberg

An Optimist’s Guide to a Chaotic World

Dr. Sethi's view on reducing ultraprocessed foods to improve U.S. life expectancy.

Expert Commentary
Expert Commentary
June 2024
The Epoch Times

Psychological effects of weight loss drugs underexplored

Cautions on GLP-1 drugs; careful, individualized prescribing; complex mind-body relationship.

Expert Commentary
Expert Commentary
May 2024
Healio

Q&A: keto diet may improve symptoms of severe mental illness

Dr. Sethi's pilot study results: ketogenic diet reversed metabolic syndrome and improved psychiatric symptoms (31% improvement).

Expert Commentary
Expert Commentary
Dec. 15, 2025
Behavioral Health Business

Mental Health's: Emerging Frontline Intervention: Metabolic Psychiatry

Metabolic psychiatry and ketogenic therapies for severe mental illness.

Media Mention
Media Mention
Oct. 2024
The New York Times

Can Drugs Like Ozempic Treat the Most Common Eating Disorder?

Cautions regarding GLP-1 drugs for binge-eating disorder; need to address underlying metabolic/psychiatric issues.

Expert Commentary
Expert Commentary

Media Inquiries

Please submit this form for interviews, press materials, or information about Metabolic Psychiatry Labs.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form, please try again.